These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8633828)

  • 21. Methotrexate and trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis.
    Yamazaki H; Nanki T; Miyasaka N; Harigai M
    J Rheumatol; 2011 Apr; 38(4):777; author reply 778. PubMed ID: 21459958
    [No Abstract]   [Full Text] [Related]  

  • 22. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
    Simonds RJ; Hughes WT; Feinberg J; Navin TR
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S44-8. PubMed ID: 8547511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
    Huang L; Morris AM; Beard CB
    J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
    [No Abstract]   [Full Text] [Related]  

  • 24. Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
    James CW; McNelis KC; Szabo S
    Am J Health Syst Pharm; 2003 Aug; 60(15):1572-4. PubMed ID: 12951757
    [No Abstract]   [Full Text] [Related]  

  • 25. Pneumocystis carinii pneumonia: pitfalls of prophylaxis.
    Massie RJ; Cooper PJ; Van Asperen PP; McIntyre P
    J Paediatr Child Health; 1998 Oct; 34(5):477-9. PubMed ID: 9767516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
    Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.
    Clotet B; Sirera G; Romeu J; Gimeno JM; Jou A; Condom MJ; Tor J; Foz M
    AIDS; 1991 May; 5(5):601-2. PubMed ID: 1863415
    [No Abstract]   [Full Text] [Related]  

  • 28. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.
    Souza JP; Boeckh M; Gooley TA; Flowers ME; Crawford SW
    Clin Infect Dis; 1999 Dec; 29(6):1467-71. PubMed ID: 10585797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
    Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
    Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dapsone in the prevention of HIV-related parasitosis].
    Garavelli PL
    Recenti Prog Med; 1996 Jun; 87(6):279. PubMed ID: 8766954
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
    Ruf B; Schürmann D; Bergmann F; Schüler-Maué W; Grünewald T; Gottschalk HJ; Witt H; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):325-9. PubMed ID: 8354297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review.
    Hughes WT
    Clin Infect Dis; 1998 Jul; 27(1):191-204. PubMed ID: 9675476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
    Urbancic KF; Pisasale D; Wight J; Trubiano JA
    Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to interpret an overview: a meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
    Easterbrook PJ
    Genitourin Med; 1997 Apr; 73(2):139-43. PubMed ID: 9215100
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
    Evans RA; Clifford TM; Tang S; Au T; Fugit AM
    Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
    Podzamczer D; Martos A; Ferrer I; Santin M; Gudiol F
    Clin Infect Dis; 1993 Jan; 16(1):171. PubMed ID: 8448298
    [No Abstract]   [Full Text] [Related]  

  • 37. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
    Opravil M; Pechère M; Lazzarin A; Heald A; Rüttimann S; Iten A; Furrer H; Oertle D; Praz G; Vuitton DA
    Clin Infect Dis; 1995 Feb; 20(2):244-9. PubMed ID: 7742423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
    J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary and secondary prophylaxis for Pneumocystis carinii related complications in HIV patients.
    Held M; Goebel FD
    Eur Respir J; 1996 May; 9(5):868-71. PubMed ID: 8793444
    [No Abstract]   [Full Text] [Related]  

  • 40. UK survey of Pneumocystis jirovecii pneumonia (PJP) prophylaxis use in paediatric oncology patients.
    Proudfoot R; Cox R; Phillips B; Wilne S
    Arch Dis Child; 2015 Jan; 100(1):115. PubMed ID: 25324566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.